Healthcare

Building on a global survey published in January 2025, Leaps by Bayer, BCG, and Ipsos announce findings from their latest qualitative research

Ipsos in the UK, working in partnership with Groundswell and Dr Stephen Green of Sheffield Hallam University, has completed an evaluation of the Rough Sleeping Drug and Alcohol Treatment Grant (RSDATG).

Ipsos polling for the King’s Fund, National Voices and Healthwatch England reveals that two in three patients (66%) have experienced at least one NHS admin problem in the last year (for themselves or someone they care for) such as lost test results, inability to change or cancel appointments, or receiving incorrect information – showing no change since 2024 (64%).

New polling finds that a significant portion of the British public is dissatisfied with the current government’s handling of negotiations with trade unions. With the highest dissatisfaction rating since this government took office, public sentiment reflects mounting concerns over worker power and public service disruptions.

For pharmaceutical, MedTech and biotech (life science) companies in the UK, the strategic focus has traditionally been on public bodies like NHS trusts and NICE. However, a potentially significant shift is underway.

Polling conducted for ITV News by Ipsos, found 65% of respondents either strongly support or tend to support the assisted dying bill being passed into law.

Trust is changing shape. Institutional trust remains under pressure.

New 14-country study from Ipsos reveals self-blame, outdated narratives and a hidden daily toll.

Latest polling from the Health Foundation and Ipsos finds that nearly half of the public have delayed or avoided contacting their GP about a health concern in the last year, due in part to access challenges. Improving access to appointments at GP practices and A&E services remains a top priority for the public when it comes to the NHS, meanwhile overall views of standards of care nationally remain negative.